Base Year
Historical Year
Forecast Year
The global selective serotonin reuptake inhibitors (SSRIs) market is expected to grow in the forecast period of 2024-2032 at a CAGR of nearly 4.2%. The market is being driven by the rising geriatric population.
-market.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
SSRIs cure depression through increasing serotonin concentrations in the brain. Serotonin is among the chemical (neurotransmitter) messengers carrying messages between brain nerve cells (neurons). SSRIs are used to block serotonin reabsorption (reuptake) into neurons. This increases the transfer of signals between neurons by more serotonin. SSRIs can also be used to treat non-depression conditions, like anxiety disorders.
-market-by-application.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market can be broadly categorised based on its applications into:
The EMR report looks into the regional markets of selective serotonin reuptake inhibitors (SSRIs) like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
-market-by-region.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increasing prevalence of mental illnesses is one of the key factors driving the expansion of the global selective serotonin reuptake inhibitors (SSRIs) industry. Mental disease has eventually become one of the most diagnosed disorders worldwide. The increasing prevalence of mental illness leads to an increased number of patients who require effective neurological therapy. In this context, mentally ill patients are more likely to opt for SSRIs for antidepressant medicines because of the improved therapeutic efficacy of SSRIs. The increased prevalence of mental illnesses is therefore expected in the forecast period to fuel the growth of the SSRI market. The application sector was being dominated by the depression segment in 2020.
The report presents a detailed analysis of the following key players in the global selective serotonin reuptake inhibitors (SSRIs) industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The global selective serotonin reuptake inhibitors (SSRIs) market is projected to grow at a CAGR of 4.2% between 2023 and 2032.
The major drivers of the industry, such as the rising disposable incomes, increasing health awareness, increasing geriatric population, and growing technological advancements, are expected to aid the market growth.
The key market trend guiding the growth of the selective serotonin reuptake inhibitors (SSRIs) industry includes the increasing prevalence and awareness of mental illnesses.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Depression, anxiety and panic disorder, and other mental conditions are the major application sectors of selective serotonin reuptake inhibitors (SSRIs) in the industry.
The major players in the industry are Allergan plc, Eli Lilly and Company, H. Lundbeck A/S, and Pfizer Inc., among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share